Full text is available at the source.
Abstract
Psilocybin, a compound derived from hallucinogenic mushrooms, has shown therapeutic potential for neuropsychiatric conditions.
- Psilocybin is metabolized into psilocin, which is responsible for its psychoactive effects.
- Recent trials have focused on orally administered synthetic psilocybin.
- Alternative formulations and delivery methods for psilocybin may provide therapeutic benefits.
- The effects of these alternative approaches are not well understood.
Simplified